Q2 2024 · 13F-HR
BRAIDWELL LPholdings as filed
Filed 2024-08-14 · accession 0001420506-24-001566
$3.19B
Reported value
75
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131MAB5 | GH 0 11/15/27 | GUARDANT HEALTH INC | $208.1M | 6.53% | 268,252,000 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $143.0M | 4.48% | 140,838,000 | Common | SOLE |
| 67011XAB9 | NVCR 0 11/01/25 | NOVOCURE LTD | $129.8M | 4.07% | 140,834,000 | Common | SOLE |
| 670704AJ4 | GMED 0.375 03/15/25 | NUVASIVE INC | $110.1M | 3.45% | 114,206,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $104.5M | 3.28% | 759,009 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $104.5M | 3.28% | 3,309,507 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $99.8M | 3.13% | 2,560,573 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $94.1M | 2.95% | 2,392,042 | Common | SOLE |
| 64049MAB6 | NEO 0.25 01/15/28 | NEOGENOMICS INC | $90.8M | 2.85% | 116,381,000 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $84.6M | 2.66% | 89,740,000 | Common | SOLE |
| 252131AM9 | DXCM 0.375 05/15/28 | DEXCOM INC | $81.2M | 2.55% | 82,700,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $81.1M | 2.54% | 2,807,968 | Common | SOLE |
| 45784PAK7 | PODD 0.375 09/01/26 | INSULET CORP | $74.4M | 2.33% | 68,000,000 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $74.0M | 2.32% | 1,669,720 | Common | SOLE |
| 252131AK3 | DXCM 0.25 11/15/25 | DEXCOM INC | $73.8M | 2.31% | 73,500,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $71.8M | 2.25% | 166,924 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $66.4M | 2.08% | 275,207 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $64.6M | 2.03% | 9,024,037 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $61.0M | 1.91% | 808,303 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $59.1M | 1.85% | 2,514,538 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $58.8M | 1.84% | 496,576 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $58.7M | 1.84% | 1,106,905 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $56.7M | 1.78% | 526,357 | Common | SOLE |
| 02081GAB8 | ATEC 0.75 08/01/26 | ALPHATEC HLDGS INC | $56.6M | 1.77% | 58,217,000 | Common | SOLE |
| 803607AD2 | SRPT 1.25 09/15/27 | SAREPTA THERAPEUTICS INC | $55.5M | 1.74% | 43,066,000 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $52.3M | 1.64% | 65,594,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $50.8M | 1.59% | 379,443 | Common | SOLE |
| 761299AB2 | TVTX 2.5 09/15/25 | TRAVERE THERAPEUTICS INC | $48.8M | 1.53% | 56,031,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $48.2M | 1.51% | 1,141,678 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $44.9M | 1.41% | 982,209 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $44.7M | 1.40% | 100,500 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $41.8M | 1.31% | 3,035,904 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $40.8M | 1.28% | 323,509 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $40.8M | 1.28% | 2,898,639 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $39.0M | 1.22% | 70,449 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $38.4M | 1.21% | 2,058,303 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $38.3M | 1.20% | 212,594 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $31.9M | 1.00% | 1,107,770 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $28.9M | 0.91% | 4,438,232 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $28.6M | 0.90% | 189,960 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $28.4M | 0.89% | 4,150,109 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $27.0M | 0.85% | 797,268 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $25.4M | 0.80% | 1,084,400 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $23.5M | 0.74% | 611,800 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $22.9M | 0.72% | 2,194,900 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $22.2M | 0.70% | 1,382,481 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $19.7M | 0.62% | 107,179 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $19.6M | 0.61% | 3,006,799 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $14.3M | 0.45% | 1,698,768 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $13.9M | 0.44% | 8,294,950 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $13.8M | 0.43% | 517,230 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $12.9M | 0.41% | 81,900 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $11.8M | 0.37% | 1,466,610 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $11.2M | 0.35% | 1,643,770 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $10.8M | 0.34% | 2,380,704 | Common | SOLE |
| 405024AB6 | HAE 0 03/01/26 | HAEMONETICS CORP MASS | $10.4M | 0.33% | 11,500,000 | Common | SOLE |
| 88331L108 | SKIN | THE BEAUTY HEALTH COMPANY | $9.8M | 0.31% | 5,120,685 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $9.5M | 0.30% | 173,900 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $9.5M | 0.30% | 366,851 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $9.1M | 0.29% | 1,013,377 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $9.1M | 0.28% | 416,100 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $8.8M | 0.27% | 345,571 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $8.5M | 0.27% | 516,643 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $7.8M | 0.24% | 369,458 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $6.7M | 0.21% | 2,477,614 | Common | SOLE |
| 415858109 | HROW | HARROW INC | $6.2M | 0.19% | 297,188 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $5.6M | 0.17% | 205,926 | Common | SOLE |
| 232109AD0 | — | CUTERA INC | $5.0M | 0.16% | 25,240,000 | Common | SOLE |
| 232109AG3 | — | CUTERA INC | $5.0M | 0.16% | 29,000,000 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $4.8M | 0.15% | 752,541 | Common | SOLE |
| 207410AH4 | CNMD 2.25 06/15/27 | CONMED CORP | $4.5M | 0.14% | 5,000,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $3.1M | 0.10% | 176,173 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MED INC | $2.7M | 0.08% | 694,525 | Common | SOLE |
| 23306J200 | — | DBV TECHNOLOGIES S A | $2.0M | 0.06% | 2,442,504 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $1.3M | 0.04% | 164,227 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.